e-learning
resources
London 2016
Sunday, 04.09.2016
Drugs, bugs, BMI, and other problems in paediatric asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Bronchodilator responsiveness after ICS treatment
Snezhina Lazova (Sofia, Bulgaria), Snezhina Lazova, Guergana Petrova, Dimitrinka Miteva, Vera Papochieva, Penka Perenovska
Source:
International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Session:
Drugs, bugs, BMI, and other problems in paediatric asthma
Session type:
Thematic Poster
Number:
1245
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Snezhina Lazova (Sofia, Bulgaria), Snezhina Lazova, Guergana Petrova, Dimitrinka Miteva, Vera Papochieva, Penka Perenovska. Bronchodilator responsiveness after ICS treatment. Eur Respir J 2016; 48: Suppl. 60, 1245
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Small airway indices, bronchodilator response and asthma control in children
Source: International Congress 2014 – Paediatric asthma: lung function testing and more
Year: 2014
Tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: Lung function and safety
Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD
Year: 2013
Limitations of forced spirometry in the detection of bronchodilator response in asthmatic children
Source: International Congress 2015 – Paediatric respiratory physiology
Year: 2015
Prediction of asthma control and treatment changes in obstructive asthmatic children
Source: International Congress 2016 – Techniques and tools in paediatric asthma
Year: 2016
Based on what parameters of clinical remission should inhaled corticosteroids be stopped in children with asthma?
Source: Annual Congress 2013 –The best of paediatric asthma and allergy
Year: 2013
Factors influencing compliance to PEF monitoring in asthma
Source: Annual Congress 2013 –Asthma treatment and management in children
Year: 2013
Assessment of bronchodilator response by airway resistance measurement using the interrupter resistance (Rint) technique in preschool children
Source: International Congress 2014 – Paediatric asthma: lung function testing and more
Year: 2014
Lung clearance index in pediatric patients with asthma
Source: Annual Congress 2013 –Asthma treatment and management in children
Year: 2013
Use of CARAT® and pulmonary function tests to assess asthma control during pregnancy
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
Computer bronchophonography (CBPG) – Method of assessment of respiratory function in asthmatic children
Source: Annual Congress 2013 –Asthma treatment and management in children
Year: 2013
Induced sputum in children With persistent asthma: The effect to inhaled corticosteroid treatment
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013
FeNO in children with asthma is related to inhaled corticosteroids adherence, not to asthma control
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014
Lung clearance index in asthmatic patients
Source: International Congress 2016 – Techniques and tools in paediatric asthma
Year: 2016
Long-acting beta2 agonist without concomitant inhaled corticosteroids in children with asthma in primary care
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014
Comparative effectiveness of paediatric asthma step-up options: Increasing ICS dose vs adding separate LABA
Source: International Congress 2014 – Paediatric asthma: what is new for the clinician?
Year: 2014
Positive bronchodilator response is a poor predictor of future risk in well controlled asthma patients
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016
Body-plethysmographic measurements of bronchodilator response in stable COPD
Source: International Congress 2014 – Airways: reversibility and responsiveness
Year: 2014
A pilot study for markers which can reflect asthmatic activity before and after reduction of inhaled corticosteroids
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Adherence to the treatment of patients with bronchial asthma
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
Assessing bronchodilator response (BDR) in preschool children using spirometry
Source: International Congress 2014 – Paediatric asthma: lung function testing and more
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept